Relmada Therapeutics, Inc. (RLMD): 10-Q filed May 12, 2026

Form type

10-Q

Filing date

May 12, 2026

Accession number

0001213900-26-055059

Filer

Relmada Therapeutics, Inc. (CIK 1553643)